We are always looking for people willing to be reviewers for the journal - we have developed this survey to let you tell us if you are willing to be a reviewer and what topics you’d like to review on for @TheTxIDjournal!. @AST_IDCOP @ttsorg .

So excited to see this CPC out from @JennCuellarR and colleagues from @NIAIDNews about a case of Acanthamoeba in an HSCT recipient. Exemplary case and great work finding the potential source.

@monicaslavin Lastly, we are also excited to welcome @benwteh as our newest Associate Editor with a focus on Onc ID/HSCT ID. Please help me in congratulating Ben on joining the editorial leadership team!.

We also want to thank @monicaslavin for her hard work and dedication as an Associate Editor and editor responsible for reviews. Monica is going to rotate off as associate editor and join our editorial board. Please help me in thanking Monica!.

As the year comes to an end its an opportunity to acknowledge all who have contributed to @TheTxIDjournal and to recognize changes in our editorial team. We thank all of the reviewers and outline the key accomplishments of the journal in 2024 here:.

RT @adm_stewart: A fantastic Special Edition with some great papers in @TheTxIDjournal.

So excited to have the Donor-Derived Infection Special Edition out - thanks to @StephaniePouch and @karenmjwaller for being guest editors for this special edition!.

This award is named after Bob Rubin, one of the early leaders in the field of #TxID. He was also the first editor of @TheTxIDjournal. He was passionate about defining the optimal approach to prevention and management of infections in ICHs.

Congratulations to @nischalr3 and his team for their paper being selected as the @TheTxIDjournal 2024 Bob Rubin Clinical Impact Awardee - this award selects the paper felt to have the biggest impact on clinical care in #TxID! . Congrats!.

RT @TransplantIDNet: Kidney txp safe for patients on #tuberculosis treatment?. @TheTxIDjournal series 30 pt in India suggests yes!. 2+ mos.….

Reminder - we will are looking for a new Associate Editor focused of HSCT/Oncology ID - see Tweet for detail - please submit CV and cover letter to tidedjournal@gmail.com by November 8.

Most recent issue is out for @TheTxIDjournal - lots of great papers but 3 focused on allergies: . A paper on the impact of sulfa-allergy labels on infection outcome & an experiences from the field about implementing delabeling from @TrubianoJason et al.

RT @AJTfellows: Deadline is approaching!.

RT @MichaelGIsonMD: Want to learn the current state of the art for prevention of RVI in immunocompromised patients?. Join us for the next @….

We continue to move papers previously rejected at other journals through quickly!. Got a paper that was rejected at another journal - consider @TheTxIDjournal instead of other journals. Its free and we’ll get your a decision generally within a few weeks.

RT @JoshuaHillMD: Interested in learning about the cutting edge in management of infections in HCT, CAR-T, and SOT recipients? Pls mark you….

We welcome applications from all interested persons with a clinical and/or research focus on HSCT/Oncology ID. Ideally the individual would be from the Asia-Pacific-Oceana region. If there are questions, please email tidedjournal@gmail.com.

If you are interested, please send a cover letter (no more than 2 pages) that discusses your interest in the role and your experience in thoracic transplantation as well as your current CV. Please send these two documents to tidedjournal@gmail.com by November 8.

The role involves joining quarterly editorial meetings (1 hour), handling about 1 new paper per week to organize reviewers and make acceptance decisions, and to potentially work on special projects of the journal (about 30 min per week).

@TheTxIDjournal is seeking applications for those interested in joining the editorial team as an Associate Editor. We are specifically seeking someone who has clinical and research experience focused on HSCT/Oncology ID for this position.